Rask Invest Research Team

The Rask Invest research team produces daily ASX news and research on ASX-listed companies and funds. Join the conversation inside the free investor community. Click here to have your say.

99% of long-term investing is doing nothing; the other 1% changes your life

Rask Invest Research Team's latest insights

Today's ASX news

2 ASX shares I can’t ignore: PME and SOL

The Pro Medicus Limited (ASX:PME) share price is up 57.3% since the start of 2024. It’s probably worth asking, ‘is the PME share price good value?’

Better investing starts here.

Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best  insights.

Skip to content